Alector ALEC
NASDAQ ALEC
$2.46 -0.05 (-1.99%)
At close: Sep 4, 2026 · 4:00 PM EDT

Alector (ALEC) Cash from Operations (2018 - 2026)

Alector's (ALEC) quarterly Cash from Operations came in at -$34.2 million in Q2 2026, up 30.23% year-over-year from -$26.3 million in Q2 2025, and up 31.31% quarter-over-quarter from -$49.8 million in Q1 2026.

Analysis

Alector (ALEC) Cash from Operations (2018 - 2026) Analysis & Trends

Alector (ALEC) has reported Cash from Operations for 9 consecutive years, with -$34.2 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Cash from Operations rose 30.23% year-over-year to -$34.2 million in Q2 2026; TTM through Jun 2026 was -$158.2 million, a 26.61% increase from a year earlier, with the FY2025 full-year figure at -$184.0 million, up 19.95% from the prior year.
  • Cash from Operations was -$34.2 million for Q2 2026 at Alector, up from -$49.8 million in the prior quarter.
  • Over five years, Cash from Operations peaked at $135.1 million in Q1 2022 and troughed at -$62.8 million in Q2 2024.
  • A 5-year average of -$39.0 million and a median of -$49.0 million in 2022 frame the typical range for Cash from Operations.
  • Across the five-year window, Cash from Operations surged 356.37% in 2022 and sank 135.94% in 2023, its largest moves.
  • Over 5 years, Cash from Operations stood at -$48.9 million in 2022, then rose by 5.84% to -$46.1 million in 2023, then decreased by 19.44% to -$55.0 million in 2024, then advanced by 24.24% to -$41.7 million in 2025, then grew by 17.93% to -$34.2 million in 2026.
  • The last three Cash from Operations figures came in at -$34.2 million (Q2 2026), -$49.8 million (Q1 2026), and -$41.7 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn 4.00 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 3.57 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 1.13 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 813.00 Mn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn -
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn -526.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn 326.72 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn 448.90 Mn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn -88.83 Mn
10 Alector 274.68 Mn 101.88 Mn - -34.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -34.22 Mn
Mar 31, 2026 -49.81 Mn
Dec 31, 2025 -41.69 Mn
Sep 30, 2025 -32.51 Mn
Jun 30, 2025 -49.05 Mn
Mar 31, 2025 -60.78 Mn
Dec 31, 2024 -55.03 Mn
Sep 30, 2024 -50.73 Mn
Jun 30, 2024 -62.80 Mn
Mar 31, 2024 -61.35 Mn
Dec 31, 2023 -46.07 Mn
Sep 30, 2023 -46.54 Mn
Jun 30, 2023 -43.00 Mn
Mar 31, 2023 -48.55 Mn
Dec 31, 2022 -48.93 Mn
Sep 30, 2022 -49.05 Mn
Jun 30, 2022 -57.44 Mn
Mar 31, 2022 135.09 Mn
Dec 31, 2021 -49.27 Mn
Sep 30, 2021 445.05 Mn